Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-10 21:46:55 UTC |
---|
Update Date | 2021-09-26 22:52:31 UTC |
---|
HMDB ID | HMDB0244634 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea |
---|
Description | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. Based on a literature review very few articles have been published on 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea. This compound has been identified in human blood as reported by (PMID: 31557052 ). 1-(3-methylphenyl)-3-[(3r)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3h-1,4-benzodiazepin-3-yl]urea is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1=CC(NC(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)=CC=C1 InChI=1S/C32H28N4O3/c1-21-11-10-15-24(19-21)33-32(39)35-30-31(38)36(20-28(37)25-16-7-6-12-22(25)2)27-18-9-8-17-26(27)29(34-30)23-13-4-3-5-14-23/h3-19,30H,20H2,1-2H3,(H2,33,35,39) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C32H28N4O3 |
---|
Average Molecular Weight | 516.601 |
---|
Monoisotopic Molecular Weight | 516.216140778 |
---|
IUPAC Name | 3-(3-methylphenyl)-1-{1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl}urea |
---|
Traditional Name | 3-(3-methylphenyl)-1-{1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl}urea |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=CC(NC(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)=CC=C1 |
---|
InChI Identifier | InChI=1S/C32H28N4O3/c1-21-11-10-15-24(19-21)33-32(39)35-30-31(38)36(20-28(37)25-16-7-6-12-22(25)2)27-18-9-8-17-26(27)29(34-30)23-13-4-3-5-14-23/h3-19,30H,20H2,1-2H3,(H2,33,35,39) |
---|
InChI Key | YCXFHPUBGMMWJQ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbonyl compounds |
---|
Direct Parent | Alkyl-phenylketones |
---|
Alternative Parents | |
---|
Substituents | - Alkyl-phenylketone
- Benzodiazepine
- 1,4-benzodiazepine
- Alpha-amino acid or derivatives
- N-phenylurea
- Benzoyl
- Aryl alkyl ketone
- Toluene
- Monocyclic benzene moiety
- Benzenoid
- Tertiary carboxylic acid amide
- Carboxamide group
- Ketimine
- Lactam
- Urea
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic oxide
- Imine
- Hydrocarbon derivative
- Organic nitrogen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TMS,isomer #1 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)=C1 | 4274.8 | Semi standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TMS,isomer #1 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)=C1 | 4036.5 | Standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TMS,isomer #1 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)=C1 | 6140.9 | Standard polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TMS,isomer #2 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)=C1 | 4428.8 | Semi standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TMS,isomer #2 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)=C1 | 4022.0 | Standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TMS,isomer #2 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)=C1 | 6333.3 | Standard polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,2TMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)[Si](C)(C)C)=C1 | 4251.3 | Semi standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,2TMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)[Si](C)(C)C)=C1 | 3976.9 | Standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,2TMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C)[Si](C)(C)C)=C1 | 5706.5 | Standard polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 4463.8 | Semi standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 4250.6 | Standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)NC2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 6068.8 | Standard polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TBDMS,isomer #2 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 4594.3 | Semi standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TBDMS,isomer #2 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 4232.0 | Standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,1TBDMS,isomer #2 | CC1=CC=CC(NC(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)=C1 | 6203.9 | Standard polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,2TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 4585.5 | Semi standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,2TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 4410.8 | Standard non polar | 33892256 | 1-(3-Methylphenyl)-3-[(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea,2TBDMS,isomer #1 | CC1=CC=CC(N(C(=O)N(C2N=C(C3=CC=CC=C3)C3=CC=CC=C3N(CC(=O)C3=CC=CC=C3C)C2=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 5650.5 | Standard polar | 33892256 |
| Show more...
---|